(1995). A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.
(2004). Assessing reproducibility for interval data in health-related quality of life questionnaires: which coefficient should be used? Qual Life Res
(1979). Czerlinsky T: Symptomatic volunteers in multicenter drug trials. Prog Neuropsychopharmacol Biol Psychiatry
(1970). Differential response to chlorpromazine, imipramine and placebo. A study of subgroups of depressed patients. Arch Gen Psychiatry
(1982). Differentiating anxiety and depression in anxiety disorders: use of rating scales. Psychopharmacol Bull
(2000). Doubleblind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks. Psychiatry Res
(1976). ECDEU assessment manual for psychopharmacology
(2005). Effects of lorazepam on fearpotentiated startle responses in man.
(2003). Fleishaker JC: Anticipatory anxiety in moderately to highly-anxious oral surgery patients as a screening model for anxiolytics: evaluation of alprazolam.
(2006). Food and Drug Administration: Guidance for industry: Patient-reported outcome measures--Use in medical product development to support labeling claims. In Draft guidance released for comment on February 3,
(1998). Foreland AR: Direct assessment of improvement in winter depression with a visual analogue scale: high reliability and validity. Psychiatry Res
(2003). GR: Defining clinically meaningful change in health-related quality of life.
(1989). Guyatt GH: Measurement of health status: ascertaining the minimal clinically important difference. Controlled Clin Trials
(1976). Hogg MI: The reliability of linear analogue scales for evaluating pain. Anaesthesia
(1976). Huskisson EC: Graphic representation of pain. Pain
(1981). Ignelzi RJ: Measurement of pain: patient preference does not confound pain measurement. Pain
(2000). IM: d-Fenfluramine in panic disorder: a dual role for 5-hydroxytryptamine. Psychopharmacology
(1989). In Educational measurement 3rd edition.
(1979). Intraclass correlations: uses in assessing rater reliability. Psychol Bull
(1987). JL: A comparison of Likert and visual analogue scales for measuring change in function.
(2003). Liu-Dumaw M: Pregablalin in generalized anxiety disorder: a placebo-controlled trial.
(1990). Lowe NK: A critical review of visual analogue scales in the measurement of clinical phenomena. Res Nurs Health
(2000). M: SF-36 Health Survey: Manual and interpretation guide. Lincoln RI: QualityMetric Incorporated;
(1987). Measuring change over time: assessing the usefulness of evaluative instruments.
(2002). Pharmacotherapy of generalized anxiety disorder.
(2009). Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation -Quality of Life questionnaire in prucalopride (RESOLOR®) trials for chronic constipation. Neurogastroenterol Motil
(1993). Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull
(1981). Reproducibility along a 10 cm vertical visual analogue scale. Ann Rheum Dis
(2001). Responsiveness of visual analogue and McGill pain scale measures.
(1996). SC: Development of a new type of global quality of life scale, and comparison of performance and preference for 12 global scales. Qual Life Res
(1992). Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care
(1983). Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand
(2004). Sprangers MAG: Is a single-item visual analogue scale as valid, reliable and responsive as multi-item scales in measuring quality of life? Qual Life Res
(1988). Statistical power analysis for the behavioral sciences. Hillsdale NJ: Lawrence Erlbaum;
(2005). Streiner DL: Validation of a revised visual analogue scale for premenstrual mood symptoms: results from prospective and retrospective trials.
(1989). TC: Chiropractic chronic low back pain sufferers and self-report assessment methods: I. A reliability study of the visual analogue scale, the pain drawing, and the McGill Pain Questionnaire. J Manipulative Physiol Ther
(1959). The assessment of anxiety states by rating.
(1991). The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. Palliat Care
(2000). Validation of the Edmonton Symptom Assessment Scale. Cancer
(1999). Wolinsky FD: Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.
(2003). Wyrwich KW: Interpretation of changes in healthrelated quality-of-life: the remarkable universality of half a standard deviation. Med Care
(1994). Zigmond AS: The Hospital Anxiety and Depression Scale Manual.